Back
“Beam Therapeutics walked away from arbitration with nothing, as a tribunal ruled its rival's AATD drug does not infringe its field rights, ending Beam's chance to collect damages or block the competing program from advancing to the clinic.”
Source
Matthew HerperX“Prime Medicine claims victory in gene-editing di…”span
“Prime Medicine claims victory in gene-editing dispute with Beam Therapeutics”
Performance
Entry$36.39
Current$36.44
Since call-0.13%
Confidence72%
How this was scored
Judged byLLM · qwen/qwen3-coder-nextconfidence 95%
Horizon2026-07-08parsed as iso-date
ResolvedJul 10, 2026 · 13:42 UTC
The prediction and summary both state that Beam Therapeutics lost the arbitration and walked away with nothing, and the evidence confirms Prime Medicine claimed victory in the dispute; since the deadline was 2026-07-08 and today is 2026-07-10, the event occurred before the deadline and was publicly reported.